Maureen Japha is the Executive Director for Environment Shaping in Corporate Affairs for Eli Lilly and Company’s Neuroscience business unit. In this role, Maureen focuses on regulatory policy, value, and access issues connected with Lilly’s Neuroscience portfolio, with a specific focus on Lilly’s Alzheimer’s disease therapeutics and diagnostics. Maureen’s prior roles at Lilly include serving as the policy lead for Lilly’s Biomeds business unit, working across immunology, pain, and migraine.
Maureen has over 15 years of experience in the field of health policy. Based in D.C., Maureen started her career as a Hatch-Waxman litigator at Covington & Burling, LLP before transitioning into health policy with roles at FasterCures, PhRMA, and PWR. Maureen holds a BS in Biology from Tufts University and a JD from Washington University School of Law.